Phase II Trial of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Anal cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 22 Sep 2016 According to Montefiore Einstein Center for Cancer Care media release, new study findings will be presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
- 14 Jun 2016 Status changed from active, no longer recruiting to completed.